Robert Ang
CEO,
Vor Biopharma
Mark Battaglini
SVP, Global Corporate Affairs & US Government Payer,
bluebird bio
Amy Butler
President, Biosciences,
Thermo Fisher Scientific
Bradley Campbell
President and Chief Operating Officer,
Amicus Therapeutics
Miguel Forte
Chief Executive Officer,
Bone Therapeutics
Bobby Gaspar
CEO,
Orchard Therapeutics
Jerry Keybl
Senior Director, Cell & Gene Therapy,
MilliporeSigma
Brett Kopelan
Executive Director,
Debra of America
Dave Lennon
CEO,
Satellite Bio
Bruce Levine
Founding Director, Clinical Cell and Vaccine Production Facility,
Abramson Cancer Center, University of Pennsylvania
Tim Lu
Chief Executive Officer,
Senti Biosciences
John Maslowski
Chief Commercial Officer,
Forge Biologics
Chris Mason
Chief Scientific Officer,
AVROBIO
Debra Miller
Founder & Chief Executive Officer,
CureDuchenne
Claudia Mitchell
Senior VP, Product and Portfolio Strategy,
Astellas Pharma
Alison Moore
Chief Technology Officer,
Allogene Therapeutics
Adora Ndu
Chief Regulatory Affairs Officer,
bridgebio
Susan Nichols
President & CEO,
Propel BioSciences
Emile Nuwaysir
CEO,
Ensoma
Karah Parschauer
Chief Legal Officer,
Ultragenyx
Louise Rodino-Klapac
Executive Vice President, Chief Scientific Officer,
Sarepta Therapeutics
Jeff Ross
Chief Executive Officer,
Miromatrix Medical
Laura Sepp-Lorenzino
Executive Vice President and Chief Scientific Officer,
Intellia Therapeutics
R.A. Session
President, Founder & CEO,
Taysha Gene Therapies
Curran Simpson
Senior Vice President, Product Development, and Chief Technical Officer,
REGENXBIO
Bob Smith
Senior Vice President, Global Gene Therapy Business,
Pfizer
Devyn Smith
CEO,
Arbor Biotechnologies
Joe Tarnowski
Senior Vice President of Cell and Gene Therapy Platforms, Medicinal Science & Technology, R&D,
GlaxoSmithKline
Arthur Tzianabos
President and Chief Executive Officer,
Homology Medicines
Christopher Vann
SVP, Chief Operating Officer,
Autolus Therapeutics
Kristin Yarema
CCO,
Atara Bio
